ArticleTherapeutics and clinical risk management2013

New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus.

Elisavet Paplomata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.